Isolation and profiling of single circulating tumor cells in myeloma: a new workflow for liquid biopsies
{{output}}
Minimal residual disease (MRD) is a key prognostic marker for progression-free and overall survival in multiple myeloma (MM). Existing high sensitivity assays primarily focus on tumor burden assessment, rely on bone marrow sampling, and are limited in their ab... ...
